XML 19 R33.htm IDEA: XBRL DOCUMENT
v2.4.1.9

Summary of Significant Accounting Policies (Details Textual) (USD $) | 3 Months Ended | 12 Months Ended | 0 Months Ended
--- | --- | --- | ---
Dec. 31, 2014 | Dec. 31, 2014 | Dec. 31, 2013 | Jun. 30, 2014
Summary Of Significant Accounting Policies [Line Items] |  |  |  |
Ownership percentage attributable to Milestone | 49.90%us-gaap_MinorityInterestOwnershipPercentageByParent | 49.90%us-gaap_MinorityInterestOwnershipPercentageByParent |  |
Warranty expense |  | $ 79,017 us-gaap_ProductWarrantyExpense | $ 97,234 us-gaap_ProductWarrantyExpense |
Non-Warranty repair income |  | 60,473 mlss_NonWarrantyRepairIncome | 118,344 mlss_NonWarrantyRepairIncome |
Joint venture owned by the entity | 49.98%us-gaap_EquityMethodInvestmentOwnershipPercentage | 49.98%us-gaap_EquityMethodInvestmentOwnershipPercentage |  |
Common stock, shares issued | 21,404,494 us-gaap_CommonStockSharesIssued | 21,404,494 us-gaap_CommonStockSharesIssued | 17,759,540 us-gaap_CommonStockSharesIssued |
Gain on Dilutive Effect on Medical Joint Venture stock issuance |  |  | 1,363,650 us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther |
Purchase of additional shares | 995,000 us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativeNumberOfSharesIssuedForAllTransactions |  |  |
Purchase of additional shares, value | 447,750 us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativeProceedsReceivedOnAllTransactions |  |  |
Purchase of additional shares, price per share | $ 0.45 us-gaap_SaleOfStockPricePerShare | $ 0.45 us-gaap_SaleOfStockPricePerShare |  |
Long-lived assets for impairment |  | 0 us-gaap_ImpairmentOfLongLivedAssetsHeldForUse | 0 us-gaap_ImpairmentOfLongLivedAssetsHeldForUse |
Advertising expenses |  | 26,569 us-gaap_AdvertisingExpense | 30,104 us-gaap_AdvertisingExpense |
Weighted-average fair value of the individual options granted |  | $ 2.18 us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | $ 1.62 us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
Options |  |  |  |
Summary Of Significant Accounting Policies [Line Items] |  |  |  |
Outstanding options and warrants |  | 1,488,796 us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount / us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis = mlss_OptionsAndWarrantsMember |  |
Minimum |  |  |  |
Summary Of Significant Accounting Policies [Line Items] |  |  |  |
Estimated useful lives |  | 5 years |  |
Maximum |  |  |  |
Summary Of Significant Accounting Policies [Line Items] |  |  |  |
Estimated useful lives |  | 7 years |  |
Milestone China |  |  |  |
Summary Of Significant Accounting Policies [Line Items] |  |  |  |
Joint venture owned by the entity |  |  |  | 40.00%us-gaap_EquityMethodInvestmentOwnershipPercentage / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = country_CN
Investment in joint venture | 348,651 us-gaap_EquityMethodInvestments / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = country_CN | 348,651 us-gaap_EquityMethodInvestments / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = country_CN |  | 1,000,000 us-gaap_EquityMethodInvestments / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = country_CN
Distributor price per instrument |  |  |  | $ 1,295 mlss_DistributorPricePerInstrument / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = country_CN
Loss on Joint Ventures |  | $ (810)us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = country_CN |  | $ (2,025)us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = country_CN
Percentage of gain/loss on joint venture |  | 40.00%mlss_EquityMethodInvestmentSummarizedFinancialInformationPercentageOfNetIncomeLoss / us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis = country_CN |  |
ACS |  |  |  |
Summary Of Significant Accounting Policies [Line Items] |  |  |  |
Ownership percentage attributable to Milestone | 70.00%us-gaap_MinorityInterestOwnershipPercentageByParent / dei_LegalEntityAxis = mlss_AdvancedCosmeticSystemIncMember | 70.00%us-gaap_MinorityInterestOwnershipPercentageByParent / dei_LegalEntityAxis = mlss_AdvancedCosmeticSystemIncMember |  |
Minority interest recorded as noncontrolling interest | 30.00%us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners / dei_LegalEntityAxis = mlss_AdvancedCosmeticSystemIncMember | 30.00%us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners / dei_LegalEntityAxis = mlss_AdvancedCosmeticSystemIncMember |  |
Milestone Medical Inc |  |  |  |
Summary Of Significant Accounting Policies [Line Items] |  |  |  |
Joint venture owned by the entity | 50.00%us-gaap_EquityMethodInvestmentOwnershipPercentage / dei_LegalEntityAxis = mlss_MilestoneMedicalIncMember | 50.00%us-gaap_EquityMethodInvestmentOwnershipPercentage / dei_LegalEntityAxis = mlss_MilestoneMedicalIncMember | 45.50%us-gaap_EquityMethodInvestmentOwnershipPercentage / dei_LegalEntityAxis = mlss_MilestoneMedicalIncMember |
Common stock, shares issued |  |  | 2,000,000 us-gaap_CommonStockSharesIssued / dei_LegalEntityAxis = mlss_MilestoneMedicalIncMember |

X
- Definition Distributor price per instrument. + References No definition available. + Details
Name: | mlss_DistributorPricePerInstrument
Namespace Prefix: | mlss_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Equity method investment summarized financial information percentage of net income loss. + References No definition available. + Details
Name: | mlss_EquityMethodInvestmentSummarizedFinancialInformationPercentageOfNetIncomeLoss
Namespace Prefix: | mlss_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Non warranty repair income. + References No definition available. + Details
Name: | mlss_NonWarrantyRepairIncome
Namespace Prefix: | mlss_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | mlss_SummaryOfSignificantAccountingPoliciesLineItems
Namespace Prefix: | mlss_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 720 -SubTopic 35 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848 + Details
Name: | us-gaap_AdvertisingExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Antidilution -URI http://asc.fasb.org/extlink&oid=6505113 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Diluted Earnings Per Share -URI http://asc.fasb.org/extlink&oid=6510752 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Contingent Stock Agreement -URI http://asc.fasb.org/extlink&oid=6508534 + Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 + Details
Name: | us-gaap_CommonStockSharesIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise of dilutive convertible securities excluding adjustments related to ESOP convertible preferred stock, stock options, and restrictive stock units. + References No definition available. + Details
Name: | us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (a)(1) -URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33918-111571 + Details
Name: | us-gaap_EquityMethodInvestmentOwnershipPercentage
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.12) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=35755396&loc=d3e33749-111570 + Details
Name: | us-gaap_EquityMethodInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The amount of net income (loss) reported by an equity method investment of the entity. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(g)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33918-111571 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33912-111571 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 28 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph bb -Article 1 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph g -Subparagraph 1, 2 -Article 4 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph w -Article 1 + Details
Name: | us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=8077374&loc=d3e2420-110228 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6391110&loc=d3e2921-110230 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 958 -SubTopic 225 -Section 45 -Paragraph 11 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=28367520&loc=d3e92212-112881 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Impairment -URI http://asc.fasb.org/extlink&oid=6515133 + Details
Name: | us-gaap_ImpairmentOfLongLivedAssetsHeldForUse
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity. + References No definition available. + Details
Name: | us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition The parent entity's interest in net assets of the subsidiary, expressed as a percentage. + References No definition available. + Details
Name: | us-gaap_MinorityInterestOwnershipPercentageByParent
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition The expense charged against earnings for the period pertaining to standard and extended warranties on the entity's goods and services granted to customers. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 460 -SubTopic 10 -Section 50 -Paragraph 8 -Subparagraph ((c)(3,4)) -URI http://asc.fasb.org/extlink&oid=6398077&loc=d3e12565-110249 + Details
Name: | us-gaap_ProductWarrantyExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment. + References No definition available. + Details
Name: | us-gaap_PropertyPlantAndEquipmentUsefulLife
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockPricePerShare
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d)(1) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Cumulative number of shares issued or sold by the subsidiary or equity method investee on all stock transactions. + References No definition available. + Details
Name: | us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativeNumberOfSharesIssuedForAllTransactions
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Cumulative amount of cash and other consideration received by subsidiary or equity method investee in exchange for shares or stock issued or sold. Include amounts of cash received, fair value of non-cash assets received, fair value of liabilities assumed, and fair value of any other forms of consideration. + References No definition available. + Details
Name: | us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativeProceedsReceivedOnAllTransactions
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | dei_LegalEntityAxis=mlss_AdvancedCosmeticSystemIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=mlss_MilestoneMedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=mlss_OptionsAndWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RangeAxis=us-gaap_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RangeAxis=us-gaap_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=country_CN
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |